Home / Going-concern warnings / Carisma Therapeutics Inc.
Filed 2025-05-13 路 Form 10-Q 路 Accession 0001628280-25-025144 nano
Price before filing: $0.193 (2025-05-12 close, split/dividend-adjusted)
Market cap at flag: $7.8M (2025-05-13) 路 Latest: $20,894 (2026-10-16)
| Window | CARM | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +184.0% | +3.6% | +180.5% | 2025-06-12 |
| 90 days | +42.7% | +9.4% | +33.3% | 2025-08-11 |
| 180 days | -75.1% | +17.6% | -92.7% | 2025-11-10 |
| 1 year | -99.9% | +28.8% | -128.7% | 2026-05-13 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"As a result of these conditions, substantial doubt exists about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.